Company · business model
Three businesses, one scientific engine.
The Large Botanical Model is the core technology. Regulatory and development solutions are its first commercial use and the place its models are validated. Owned ingredients and intellectual property are a longer-term way to create value from the same capabilities.
ProposedNo product, customer, license or revenue exists yet. This page describes the intended model; prices and terms are not published.
01 · The model
Projects pay first; validated capabilities become products.
Business 1 · later
Enterprise scientific AI platform
Software licenses, subscriptions, specialized research modules, API access and data-supported development workflows.
Future product
Business 2 · first
Regulatory and development solutions
Model-assisted NDI assessment, NDIN dossier support, ingredient qualification, safety-gap analysis, extraction and formulation development, targeted experimental programs with partners.
Workflow demonstrated
Business 3 · after validation
Proprietary ingredients and IP
Promising botanical ingredients, optimized processes, delivery technologies and standardized formulations, protected where possible and commercialized by license, partners or supply.
Future objective
Every project is designed to leave a validated method, a benchmark or, with permission, data that improve the platform.
- Fixed-scope projectsFeasibility, dossier support and development programs, priced per decision.
- Validated modulesWorkflows that pass their benchmarks become reusable platform modules.
- Recurring accessClients with repeat needs move to subscriptions and API access.
- Owned programsValidated capabilities applied to EUTECNIQ-funded ingredients and licensed.
02 · Customers
Who would pay, for what, and when.
| Segment | Their problem | What they would buy | Business | When |
|---|---|---|---|---|
| International botanical suppliers | An ingredient used abroad needs a U.S. pathway and evidence | NDI feasibility; identity and contaminant packages; dossier support | Business 2 | First |
| U.S. supplement brands and distributors | A new botanical must be qualified before launch | Supplier qualification; specification; safety-gap analysis | Business 2, then 1 | First |
| Ingredient manufacturers | Standardization, process and formulation for a defined ingredient | Model-guided extraction and formulation programs | Business 2, then 1 | First |
| CROs and CDMOs | Better-chosen studies and processes for their own clients | Platform modules and API access | Business 1 | Later |
| Pharmaceutical, cosmetic and personal-care developers | Ingredient intelligence under their own pathways | Platform access; partnered programs | Business 1 | Later |
| Licensees and partners | An owned, documented ingredient or process | Licenses, partner manufacturing, supply | Business 3 | After validation |
Segments are the intended order of entry, not existing customers. The first market test is whether clients pay for a better-founded decision on a botanical candidate.
03 · Data rights
Customer data stay the customer’s.
Default
Not training data
Customer proprietary data are used only for that customer’s work and do not become EUTECNIQ training data unless the customer agrees in writing.
Ownership
Clear in every contract
Clients own their deliverables; EUTECNIQ keeps its pre-existing and general methods. EUTECNIQ owns everything from its own programs.
Provenance
Only data with rights
Shared models are trained only on public, licensed or EUTECNIQ-generated data for which EUTECNIQ holds explicit rights, with the source recorded.
Audit
Traceable outputs
Every prediction and dossier statement can be traced to its inputs, model version and sources.
04 · Defensibility
What would be hard to copy, and what would not.
Many companies use AI and molecular modeling; EUTECNIQ does not claim otherwise. Defensibility would come from what accumulates: lawfully generated and licensed datasets, validated algorithms, experimental relationships that are hard to reproduce, specialized workflows, process know-how, technical partnerships and inventions protected where they are new and non-obvious. None of these exists at scale yet; building them is the plan.
Information only; not an offer of securities.
Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.
Read the full notice
The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.